| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/24/2006 | WO2006087718A1 Extension of lifespan with drugs |
| 08/24/2006 | WO2006086837A1 Non-surgical mulesing |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable |
| 08/24/2006 | US20060189695 External preparation for improving coital function |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189630 Mitotic kinesin inhibitors |
| 08/24/2006 | US20060189625 Cyclic aminophenyl sulfamate derivative |
| 08/24/2006 | US20060189621 Benzofuran derivative |
| 08/24/2006 | US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189566 Muscle building agent and preventive or remedy for muscle weakening |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189518 Preventing/remedies for cancer |
| 08/24/2006 | US20060188990 Novel prostate tumor-specific promoter |
| 08/24/2006 | US20060188953 Methods and compositions that affect melanogenesis |
| 08/24/2006 | US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 08/24/2006 | US20060188576 Pirenzepine ophthalmic gel |
| 08/24/2006 | US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells |
| 08/24/2006 | US20060188501 Diagnostic and therapeutic agents for rheumatoid arthritis |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 08/24/2006 | CA2598988A1 Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 08/24/2006 | CA2598301A1 Salt of proline derivative, solvate thereof, and production method thereof |
| 08/23/2006 | EP1693382A2 Melanocortin 1 receptor selective compounds |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1693084A1 Alga extract and lipase inhibitor containing the same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693066A2 Immortalized human keratinocyte cell line |
| 08/23/2006 | EP1693065A1 Fibroblast-mobilizing agent containing g-csf and wound remedy |
| 08/23/2006 | EP1693063A1 Antiallergic agent containing ground lotus and/or extract thereof together with lactic acid bacterium |
| 08/23/2006 | EP1692166A1 Novel muscle growth regulator |
| 08/23/2006 | EP1692131A2 Methods and compositions for slowing aging |
| 08/23/2006 | EP1691807A1 Indole derivatives for the treatment of bone diseases |
| 08/23/2006 | EP1534271B1 Antitumor compound and therapeutic uses thereof |
| 08/23/2006 | EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1404309B1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 08/23/2006 | EP1402913B1 Dry powder inhalation system for transpulmonary administration, method of manufacturing a dry powdered preparation, and use of a freeze dried composition |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 08/23/2006 | CN1823039A Cyclic aminophenyl sulfamate derivative |
| 08/23/2006 | CN1822847A Plant worms mycelium extracat fraction and composition for oral intake |
| 08/23/2006 | CN1820769A Process for preparing micrometer ginseng, tortoise, pearl and pollen wine for nourishing yin and removing fatigue |
| 08/23/2006 | CN1820768A Process for preparing micrometer ginseng, tortoise, pearl and pollen oral liquor for nourishing yin, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820767A Process for preparing micrometer ginseng, tortoise pearl pollen granules, capsule and tablet for nourishing yin, removing fatigue and supplementing granule calcium |
| 08/23/2006 | CN1820766A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen oral liquor for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820756A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 08/23/2006 | CN1820754A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/23/2006 | CN1820734A Treatment with anti-erbb2 antibodies |
| 08/23/2006 | CN1820647A Nutrition powder for increasing memory |
| 08/23/2006 | CN1820646A Health food containing paederia scandens |
| 08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 08/23/2006 | CN1271067C Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNF & alpha levels |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271055C Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/23/2006 | CN1270780C 栓塞材料 Embolic material |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/23/2006 | CN1270719C Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 08/23/2006 | CN1270718C Epiallopregnanolone in the treatment of CNS disorders |
| 08/23/2006 | CN1270714C Microemulsion preconcentrates containing piperidine substance P antagonist |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094889 AGE-1 polypeptides and related molecules and methods |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094784 High affinity ligands for nociceptin receptor ORL-1 |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094773 LTA4 hydrolase inhibitors |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |